Table II.
Multivariable analysis for 5-year overall survival.
| 5-year overall survival | ||
|---|---|---|
| Factors | P-valuea | HRb (95% CI) |
| Female gender | 0.293 | 1.376 (0.759–2.494) |
| Age | 0.627 | 1.006 (0.981–1.031) |
| Complete response | 0.019 | 0.421 (0.204–0.866) |
| Treatment | 0.540 | 1.053 (0.893–1.242) |
| SWOG pretreatment risk criteria | 0.074 | 1.724 (0.949–3.134) |
| t-AML | 0.019 | 2.404 (1.152–5.017) |
| Consolidation therapy | 0.005 | 0.342 (0.161–0.727) |
a
Chi-square test.
b
Risk of death within 5 years. HR, hazard ratio; CI, confidence interval; swog, Southwestern Oncology Group; t-AML, therapy-related acute myeloid leukemia.